REGN vs BIIB: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Biogen Inc in 2026
REGN
Regeneron Pharmaceuticals Inc
$664.52
BIIB
Biogen Inc
$199.15
Key Metrics Comparison
| Metric | REGN | BIIB | Winner |
|---|---|---|---|
| Market Cap | $59.10B | $29.33B | REGN |
| P/E Ratio | 13.91 | 21.39 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze REGN
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or BIIB a better investment?
Comparing REGN and BIIB: Regeneron Pharmaceuticals Inc has a market cap of $59.10B while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and BIIB?
REGN (Regeneron Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or BIIB?
Based on P/E ratios, REGN trades at a lower multiple (13.9x vs 21.4x).
Which is growing faster: REGN or BIIB?
Both REGN and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: REGN or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: REGN or BIIB?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $29.33B for BIIB.
Should I buy REGN or BIIB in 2026?
Both REGN and BIIB have investment merit. REGN trades at $664.52 while BIIB trades at $199.15. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and BIIB stock?
Key differences: Market Cap ($59.10B vs $29.33B), P/E Ratio (13.9x vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy REGN or BIIB in 2026?
The choice between REGN and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between REGN and BIIB?
REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B, while BIIB (Biogen Inc) has a market cap of $29.33B. REGN is the larger company by market value.